PDCD1LG2 and diabetes mellitus: Studies on mice have also explored the role of immune checkpoints in the development of diabetes mellitus, proving that the blockade of PD-1 or PD-L1 was associated with fulminant diabetes in non-obese diabetic mice, whereas this was not correlated with the blockade of PD-L2 [38].